NEW YORK – Which articles gained the most attention from GenomeWeb's readers last week? Here are the top five:
- Thermo Fisher Plans $450M Cost Reduction, Lowers 2023 Financial Guidance
- Bio-Rad Laboratories, Qiagen Settle Digital PCR Patent Dispute
- Illumina, Pillar Biosciences Ink Global Distribution Agreement for Cancer Dx Assays
- Danaher Q2 Revenues Decline 8 Percent, Beat Estimates
- Epigenomics to Sell Patents, Biobank to New Day Diagnostics